✦ LIBER ✦

865 12 WEEK RESPONSE-GUIDED TREATMENT WITH THE NS5A INHIBITOR, GS-5885, THE NS3 PROTEASE INHIBITOR, GS-9451, PLUS PEGYLATED INTERFERON/RIBAVIRIN IN TREATMENT NAÏVE GENOTYPE 1 HEPATITIS C INFECTED PATIENTS

✍ Scribed by Marcellin, P.; Manns, M.P.; Janczewska, E.; Muir, A.J.; Wu, X.; Trenkle, J.D.; Kanwar, B.; Subramanian, M.; McHutchison, J.G.; Gordon, S.C.; Jacobson, I.M.

Book ID: 122940087
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 57 KB
Volume: 58
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(13)60867-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

13 COMBINATION OF THE NS5A INHIBITOR, GS

13 COMBINATION OF THE NS5A INHIBITOR, GS-5885, THE NS3 PROTEASE INHIBITOR, GS-9451, AND PEGYLATED INTERFERON PLUS RIBAVIRIN IN TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 HEPATITIS C INFECTION

✍ Everson, G.T.; Di Bisceglie, A.M.; Vierling, J.M.; Hsieh, F.; Trenkle, J.D.; Kan 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 64 KB

68 ANTIVIRAL EFFICACY OF THE NS3 PROTEAS

68 ANTIVIRAL EFFICACY OF THE NS3 PROTEASE INHIBITOR, GS-9451, NON-NUCLEOSIDE NS5b INHIBITOR, TEGOBUVIR, AND PEGYLATED INTERFERON PLUS RIBAVIRIN IN TREATMENT-NAÏVE GENOTYPE 1 HEPATITIS C INFECTED PATIENTS

✍ Pol, S.; Jablkowski, M.; Trenkle, J.D.; Kanwar, B.; Bekele, B.N.; Subramanian, M 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB